Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,497 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Endothelial Glycocalyx in the Peripheral Capillaries is Injured Under Oxaliplatin-Induced Neuropathy.
Kuroda T, Suzuki A, Okada H, Shimizu M, Watanabe D, Suzuki K, Mori K, Ohmura K, Niwa A, Imaizumi Y, Matsuo M, Ichihashi K, Okubo T, Taniguchi T, Kanayma T, Kobayashi R, Sugie S, Hara A, Tomita H. Kuroda T, et al. Among authors: okada h. J Pain. 2024 Jan 10:104462. doi: 10.1016/j.jpain.2024.01.005. Online ahead of print. J Pain. 2024. PMID: 38211844 Free article.
Recombinant thrombomodulin may protect cardiac capillary endothelial glycocalyx through promoting Glypican-1 expression under experimental endotoxemia.
Kakino Y, Doi T, Okada H, Suzuki K, Takada C, Tomita H, Asano H, Kano S, Wakayama Y, Okuda T, Fukuda H, Nishio A, Kawasaki Y, Kuroda A, Shimada T, Takashima S, Suzuki K, Yoshimura G, Kamidani R, Yasuda R, Fukuta T, Kitagawa Y, Okamoto H, Miyake T, Suzuki A, Yoshida T, Tetsuka N, Yoshida S, Ogura S. Kakino Y, et al. Among authors: okada h. Heliyon. 2022 Oct 25;8(11):e11262. doi: 10.1016/j.heliyon.2022.e11262. eCollection 2022 Nov. Heliyon. 2022. PMID: 36353180 Free PMC article.
Investigation of the relationship between intradialytic hypotension during hemodialysis and serum syndecan-1 concentration.
Oiwa H, Okada H, Suzuki K, Sumi K, Yoshida S, Suzuki K, Ishihara T, Kitagaki H, Kimura K, Naito Y, Chiba N, Kuroda A, Uchida A, Fukuda H, Kawasaki Y, Minamiyama T, Nishio A, Shimada T, Kamidani R, Miura T, Tochibora R, Yamamoto S, Kinomura Y, Kitagawa Y, Fukuta T, Miyake T, Yoshida T, Suzuki A, Tetsuka N, Tomita H, Nawa T, Ogura S. Oiwa H, et al. Among authors: okada h. Sci Rep. 2023 Oct 5;13(1):16753. doi: 10.1038/s41598-023-44094-7. Sci Rep. 2023. PMID: 37798324 Free PMC article.
Decreased neutrophil counts prolong inflammation in acute pancreatitis and cause inflammation spillover to distant organs.
Fukuda Y, Mori K, Okada H, Tomita H, Suzuki K, Takada C, Kamidani R, Kawasaki Y, Fukuda H, Minamiyama T, Nishio A, Shimada T, Kuroda A, Uchida A, Kitagawa Y, Fukuta T, Miyake T, Yoshida T, Suzuki A, Tetsuka N, Yoshida S, Ogura S. Fukuda Y, et al. Among authors: okada h. Pancreatology. 2023 Dec;23(8):911-918. doi: 10.1016/j.pan.2023.10.020. Epub 2023 Nov 3. Pancreatology. 2023. PMID: 37981522 Free article.
Nafamostat mesylate decreases skin flap necrosis in a mouse model of type 2 diabetes by protecting the endothelial glycocalyx.
Fukuda Y, Okada H, Tomita H, Suzuki K, Mori K, Takada C, Kawasaki Y, Fukuda H, Minamiyama T, Nishio A, Shimada T, Kuroda A, Uchida A, Suzuki K, Kamidani R, Kitagawa Y, Fukuta T, Miyake T, Yoshida T, Suzuki A, Tetsuka N, Yoshida S, Ogura S. Fukuda Y, et al. Among authors: okada h. Biochem Biophys Res Commun. 2024 May 28;710:149843. doi: 10.1016/j.bbrc.2024.149843. Epub 2024 Apr 3. Biochem Biophys Res Commun. 2024. PMID: 38593617 Free article.
Combination therapy for hypertension in patients with CKD: a subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial.
Rakugi H, Ogihara T, Umemoto S, Matsuzaki M, Matsuoka H, Shimada K, Higaki J, Ito S, Kamiya A, Suzuki H, Ohashi Y, Shimamoto K, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group. Rakugi H, et al. Hypertens Res. 2013 Nov;36(11):947-58. doi: 10.1038/hr.2013.63. Epub 2013 Jul 18. Hypertens Res. 2013. PMID: 23864054 Clinical Trial.
Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial.
Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial Group. Umemoto S, et al. Hypertens Res. 2017 Apr;40(4):376-384. doi: 10.1038/hr.2016.158. Epub 2016 Dec 1. Hypertens Res. 2017. PMID: 27904156 Free PMC article. Clinical Trial.
Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial.
Matsuzaki M, Ogihara T, Umemoto S, Rakugi H, Matsuoka H, Shimada K, Abe K, Suzuki N, Eto T, Higaki J, Ito S, Kamiya A, Kikuchi K, Suzuki H, Tei C, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group. Matsuzaki M, et al. J Hypertens. 2011 Aug;29(8):1649-59. doi: 10.1097/HJH.0b013e328348345d. J Hypertens. 2011. PMID: 21610513 Clinical Trial.
Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial.
Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events COPE Trial Group. Umemoto S, et al. Hypertens Res. 2016 Jan;39(1):46-53. doi: 10.1038/hr.2015.104. Epub 2015 Oct 22. Hypertens Res. 2016. PMID: 26490089 Free PMC article. Clinical Trial.
4,497 results